WebMD Health Corp.’s first-quarter profit rose nearly 60% as the health information publisher continued to benefit from higher advertising revenue and a double-digit increase in traffic.

CVS CVS Health reported strong first quarter results with revenues at $69 billion, up 3.5% from the same period last year. Although the company generated $2.9 billion in cash flow from operations, ...

Scout Investments, Inc., an affiliate of Carillon Tower Advisers, released the “Carillon Scout Mid Cap Fund” first quarter ...

CVS Health (CVS) reported better-than-expected fourth-quarter results on Wednesday, while the healthcare company projected higher 2025 earnings on a year-over-year basis. Adjusted earnings came in ...

The ad-page retreat isn’t over yet. Magazine ad pages fell 9.4 percent in the first quarter of this year from the first quarter of 2009, to about 34,800 pages, the Publishers Information Bureau ...

Overall, CVS Health booked adjusted earnings of $2.25 per share as the company’s profit soared 60% to $1.78 billion in the year’s first quarter. Total revenue climbed 7% to $94.59 billion.

CVS Health’s adjusted fourth-quarter profit handily beat Wall Street’s estimates, ... See a newsletter example. You May Also Like. The 10 Worst Presidents.

On track to initiate the Phase 2 BLUEPRINT clinical trial of BLU-5937 in patients with chronic pruritus associated with atopic dermatitis (“AD”) in the fourth quarter of 2020.

Facebook's most-viewed page last quarter racked up 122 million views before it was taken down. The account was a popular meme page suspected of being a data-mining operation, Insider has learned.

CVS Health said on Wednesday that high demand for medical care among older adults hit second-quarter results, a trend that continued into July, causing it to slash its 2024 earnings forecast.

CVS Health hiked its 2025 forecast above Wall Street’s expectations after improving Medicare benefits contributed to a better-than-expected first quarter. The health care giant said Thursday ...

BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics ...